Commentary: Medicare must study unproven, expensive Alzheimer’s drug

The cost of caring for America’s nearly 6 million Alzheimer’s disease patients is already $600 billion a year, factoring in the cost of uncompensated caregiving. Now, the Food and Drug Administration has approved a drug treatment that may or may not work but is set to cost $56,000 a year for the average patient — a charge that in most instances will fall to Medicare.

Noah Feldman: We don’t want the Justice Department investigating Congress

All sorts of information is now spilling out about how former president Donald Trump’s Department of Justice sought to investigate leaks related to the Russia investigation. Under Trump, the department subpoenaed the confidential data of journalists and, apparently, the White House counsel. Both of these are chilling, but arguably the worst violation so far is the Justice Department’s investigation into members of Congress, including Adam Schiff, who was spearheading the Russia investigation in Congress.

Commentary: To heal the ocean, we must act fast

For millions of years, Earth’s climate has been fairly stable largely due to the ocean’s role in mediating global temperature and driving our weather cycles, determining rainfall, storms, droughts and floods. Without much attention or support from humans, the ocean has been protecting every living being on this planet from the harmful effects of climate change by absorbing and redistributing heat across the planet through its currents.

Editorial: Biden’s vaccine goal of 70% by July 4 could pass us by, and we have no one to blame but ourselves

It wasn’t that long ago that people were clamoring for COVID-19 vaccines, with some going as far as lying about their age to secure the much-in-demand but not readily available shots — back when they were meted out by age, oldest first. Now the country is in a whole other, opposite dilemma with plenty of vaccines to go around, but not enough willing people waving their arms to get them. The concern is so great that governments, including Maryland’s, and businesses are trying to entice people with incentives such as food, cash and lottery winnings.

Commentary: How foreign aid for medicine yields big economic returns

President Joe Biden’s decision to donate 500 million COVID-19 vaccines to other countries by June 2022 is an important step toward restoring the United States’ global standing. Another, parallel foreign policy solution could perhaps do even more. It is simple, cost-effective and could improve the health and well-being of billions of people — especially children.

As I See It: Our shameful DNA

Racism has always been in our shameful DNA. Jamestown, the first permanent English colony, was established in 1607. The Spanish were already colonizing Florida. Both colonies discovered that the Native Americans did not do well as slave labor. In 1619, Virginia imported the first Africans. These colonies were autocratic in one way or another. Religion used to keep people in line. It was not until 1681 that a colony established by William Penn promised religious freedom to all. The English colonists and the French colonists to their north went to war in 1754 over the intervening space, recruiting various Indian tribes as proxy soldiers.

Editorial: Biden should be better at seeing what’s ahead

In 2012, Pew Research asked 1,008 Americans to describe then-Vice President Joe Biden in one word. The responses ranged from “Good,” the most common answer, to “Goofy.” But almost five months into his tenure, the word that perhaps most accurately describes him as president is “Shortsighted.” Time after time, Biden has been caught short by consequences of his policies that should have been obvious.

Editorial: New drug for Alzheimer’s: Sound science or profit-driven?

The announcement of a new drug to treat Alzheimer’s disease was greeted this week with celebration and skepticism. The Food and Drug Administration approved the use of the drug Aduhelm over the objections of an FDA advisory committee and expert panels that questioned the medicine’s effectiveness in trials.